dactinomycin has been researched along with ubenimex in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asada, E; Furuhashi, Y; Goto, S; Ino, K; Kosaki, A; Misawa, T; Mizutani, S; Nomura, S; Tomoda, Y | 1 |
| Fontana, A; Schlapbach, R | 1 |
| Chojnowski, GM; Davern, CM; Ellem, KA; Francis, KG; Hall, PM; Piva, TJ | 1 |
3 other study(ies) available for dactinomycin and ubenimex
| Article | Year |
|---|---|
Growth inhibitory effect of bestatin on choriocarcinoma cell lines in vitro.
Topics: Aminopeptidases; Choriocarcinoma; Dactinomycin; Dose-Response Relationship, Drug; Drug Synergism; Female; Humans; Leucine; Pregnancy; Stereoisomerism; Structure-Activity Relationship; Succinate Dehydrogenase; Tumor Cells, Cultured; Uterine Neoplasms | 1991 |
Differential activity of bcl-2 and ICE enzyme family protease inhibitors on Fas and puromycin-induced apoptosis of glioma cells.
Topics: Amino Acid Chloromethyl Ketones; Antibodies, Monoclonal; Apoptosis; Caspase 1; Cell Survival; Cycloheximide; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Dactinomycin; Fas Ligand Protein; fas Receptor; Free Radical Scavengers; Glioma; Humans; Leucine; Membrane Glycoproteins; Oligopeptides; Proto-Oncogene Proteins c-bcl-2; Puromycin; Transfection; Tumor Cells, Cultured | 1997 |
Increased ecto-metallopeptidase activity in cells undergoing apoptosis.
Topics: Aminopeptidases; Apoptosis; Cell Membrane; Cisplatin; Cycloheximide; Dactinomycin; DNA Fragmentation; Flow Cytometry; HeLa Cells; Humans; Leucine; Metalloendopeptidases; Mutagens; Peptides; Protease Inhibitors; Transforming Growth Factor alpha; Ultraviolet Rays | 2000 |